Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Journal Club: a randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.

× No keyword cloud information.

15 in total

Review 1. What is meant by intention to treat analysis? Survey of published randomised controlled trials.

Authors: S Hollis; F Campbell
Journal: BMJ Date: 1999-09-11

Review 2. Statistics notes: Analysing controlled trials with baseline and follow up measurements.

Authors: A J Vickers; D G Altman
Journal: BMJ Date: 2001-11-10

Review 3. Multiple imputation: a primer.

Authors: J L Schafer
Journal: Stat Methods Med Res Date: 1999-03 Impact factor: 3.021

4. Statistical analysis of correlated data using generalized estimating equations: an orientation.

Authors: James A Hanley; Abdissa Negassa; Michael D deB Edwardes; Janet E Forrester
Journal: Am J Epidemiol Date: 2003-02-15 Impact factor: 4.897

5. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.

Authors: Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus von Bergmann; Konrad Beyreuther; Johannes Dichgans; Henning Wormstall; Tobias Hartmann; Jörg B Schulz
Journal: Ann Neurol Date: 2002-09 Impact factor: 10.422

Review 6. Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors: Christiane Reitz
Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472

7. Statistical considerations in the intent-to-treat principle.

Authors: J M Lachin
Journal: Control Clin Trials Date: 2000-06

8. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.

Authors: M Sano; K L Bell; D Galasko; J E Galvin; R G Thomas; C H van Dyck; P S Aisen
Journal: Neurology Date: 2011-07-27 Impact factor: 9.910

9. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors: G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal: Neurology Date: 1984-07 Impact factor: 9.910

10. Inter-ethnic comparisons of the pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin.

Authors: W Mück; S Unger; K Kawano; G Ahr
Journal: Br J Clin Pharmacol Date: 1998-06 Impact factor: 4.335